Sharenet Sites 
Sharenet Sites
Trading statement
Remgro Limited
(Incorporated in the Republic of South Africa)
(Registration number 1968/006415/06)
ISIN: ZAE000026480
Share code: REM
("Remgro" or "the Company")
TRADING STATEMENT
Paragraph 3.4 (b) of the Listings Requirements of the JSE Limited ("JSE Listings Requirements")
requires companies to publish a trading statement as soon as they become reasonably certain that their
financial results for the period to be reported upon next will differ by at least 20% from those of the
previous corresponding period. Remgro’s results for the six months ended 31 December 2020 are due
to be released on the Stock Exchange News Service on or about 25 March 2021.
In compliance with the JSE Listings Requirements, the following guidance is provided to Remgro
shareholders regarding the expected outcome for the six months ended 31 December 2020:
Six months ended Guidance for the six months
31 December 2019 ended 31 December 2020
(cents) Decrease Range (cents)
Total headline earnings per share 750.9 60% - 70% 225.3 – 300.4
Headline earnings per share from
continuing operations 522.5 45% - 55% 235.1 – 287.4
The results for the six months to 31 December 2020 is not directly comparable with the six months
to 31 December 2019, which was for a pre-Covid-19 period. Headline earnings for the period under
review was significantly affected by the decreased contribution of Mediclinic International plc
(Mediclinic) (down by 80.2%), which includes the full impact of the Covid -19-related lockdown
measures on their results for the six months to 30 September 2020. Furthermore, due to the
accounting reclassification of FirstRand Limited (FirstRand) from an equity accounted investment to
an investment at fair value through other comprehensive income, no earnings from FirstRand were
accounted for in the period under review, whereas R548 million was included in the comparative
period. As a result of the Covid-19 pandemic, FirstRand did not pay any dividends during the period
under review. Excluding Mediclinic and FirstRand, the rest of Remgro’s investment portfolio had a
resilient performance during the Covid-19 pandemic.
During June 2020 Remgro unbundled its 28.2% interest in RMB Holdings Limited (RMH) and
consequently the investment in RMH was treated as a discontinued operation for the year ended
30 June 2020. For the period under review headline earnings is presented for continuing operations
and discontinued operations and, accordingly, discontinued operations for the comparative six
months to 31 December 2019 include the equity accounted income of RMH.
The decrease in headline earnings from continuing operations is mainly due to lower contributions
by Mediclinic and FirstRand, as well as lower interest income, due to the 300 basis points reduction
in interest rates since January 2020.
The financial information on which this trading statement is based has not been reviewed and reported
on by the Company’s external auditors.
Stellenbosch
17 March 2021
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 17-03-2021 09:52:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
